Vertrix Wealth Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Vertrix Wealth Management's AZN Position: Q3 2026 in Review
Vertrix Wealth Management increased its AstraZeneca (AZN) stake by 18% in Q3 2026, buying an estimated $102K and bringing the position to 3,945 shares worth $637K. The position accounts for 0.22% of the portfolio, ranked #73.
Vertrix Wealth Management first reported a position in AZN in Q1 2026 and has held it in 3 quarters since. The position peaked at $650K in Q1 2026. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Vertrix Wealth Management held 3,945 shares of AstraZeneca worth $637K as of Q3 2026.
- Vertrix Wealth Management bought 611 AstraZeneca shares in Q3 2026, an estimated $102K.
- AstraZeneca made up 0.22% of Vertrix Wealth Management's portfolio in Q3 2026, its #73 holding.
- Vertrix Wealth Management first reported a position in AstraZeneca in Q1 2026 and has held it in 3 quarters since.
- Vertrix Wealth Management's AstraZeneca position peaked at $650K in Q1 2026.
- 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Vertrix Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.